These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27640317)

  • 21. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series.
    Joseph VMK; Rose EC; Edwards CJ; Lloyd M; Amar SK; Wheeler RD; Forster T; Smith KA; Eren E; Hughes R; Hajela V; Kiely PDW
    Clin Exp Rheumatol; 2022 Feb; 40(2):298-303. PubMed ID: 35200125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
    Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy.
    Keating P; Young J; George P; Florkowski C; Spellerberg M; Kennedy N
    Int J Rheum Dis; 2017 Dec; 20(12):2179-2181. PubMed ID: 28185416
    [No Abstract]   [Full Text] [Related]  

  • 25. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy.
    Llansó L; Segarra-Casas A; Domínguez-González C; Malfatti E; Kapetanovic S; Rodríguez-Santiago B; de la Calle O; Blanco R; Dobrescu A; Nascimento-Osorio A; Paipa A; Hernandez-Lain A; Jou C; Mariscal A; González-Mera L; Arteche A; Lleixà C; Caballero-Ávila M; Carbayo Á; Vesperinas A; Querol L; Gallardo E; Olivé M
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200285. PubMed ID: 39106428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease.
    Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M
    Front Immunol; 2022; 13():866701. PubMed ID: 35603214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HMGCR antibody-associated necrotizing myopathy: diagnosis and treatment illustrated using a case report.
    Giudizi MG; Cammelli D; Vivarelli E; Biagiotti R; Ferraro A; Bentow C; Almerigogna F; Albesa R; Mahler M
    Scand J Rheumatol; 2016 Oct; 45(5):427-9. PubMed ID: 26886059
    [No Abstract]   [Full Text] [Related]  

  • 28. HMGCR-associated myositis: a New Zealand case series and estimate of incidence.
    Kennedy N; Keating P; O'Donnell J
    Intern Med J; 2016 May; 46(5):622-5. PubMed ID: 27170241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin induced necrotizing autoimmune myopathy.
    Babu S; Li Y
    J Neurol Sci; 2015 Apr; 351(1-2):13-17. PubMed ID: 25765229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.
    Selva-O'Callaghan A; Alvarado-Cardenas M; Pinal-Fernández I; Trallero-Araguás E; Milisenda JC; Martínez MÁ; Marín A; Labrador-Horrillo M; Juárez C; Grau-Junyent JM
    Expert Rev Clin Immunol; 2018 Mar; 14(3):215-224. PubMed ID: 29473763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
    Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
    J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.
    Allenbach Y; Drouot L; Rigolet A; Charuel JL; Jouen F; Romero NB; Maisonobe T; Dubourg O; Behin A; Laforet P; Stojkovic T; Eymard B; Costedoat-Chalumeau N; Campana-Salort E; Tournadre A; Musset L; Bader-Meunier B; Kone-Paut I; Sibilia J; Servais L; Fain O; Larroche C; Diot E; Terrier B; De Paz R; Dossier A; Menard D; Morati C; Roux M; Ferrer X; Martinet J; Besnard S; Bellance R; Cacoub P; Arnaud L; Grosbois B; Herson S; Boyer O; Benveniste O;
    Medicine (Baltimore); 2014 May; 93(3):150-157. PubMed ID: 24797170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption.
    Parikh P; Tavee J; Soltanzadeh P; Mammen AL; McKeever P; Li Y
    Muscle Nerve; 2018 Jun; 57(6):E135-E136. PubMed ID: 29346706
    [No Abstract]   [Full Text] [Related]  

  • 36. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
    Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
    Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of anti-HMG-CoA reductase autoantibodies in severe self-limited statin-related myopathy.
    Floyd JS; Brody JA; Tiniakou E; Psaty BM; Mammen A
    Muscle Nerve; 2016 Jun; 54(1):142-4. PubMed ID: 27038110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues.
    Khoo T; Chinoy H
    Autoimmun Rev; 2023 Dec; 22(12):103468. PubMed ID: 37884200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series.
    Tiniakou E; Rivera E; Mammen AL; Christopher-Stine L
    Arthritis Rheumatol; 2019 Oct; 71(10):1723-1726. PubMed ID: 31058470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin-associated anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) myopathy: Imaging findings on thigh-muscle magnetic resonance imaging (MRI) in six patients.
    Lee KH; Gao Y; Lau V
    Muscle Nerve; 2021 Oct; 64(4):500-504. PubMed ID: 34297419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.